Top Tech Companies in Boston, MA (4,695)

Strong Revenue Growth: Recent results show accelerating top-line momentum, with FY2025 up 28% and Q2 2026 revenue up 36% year over year after 32% in Q1. Management also raised 2026 revenue guidance to $4.45B–$4.47B, indicating confidence in continued expansion.

Healthy Cash Flow: Cash generation is substantial, including Q2 2026 operating cash flow of $316M and free cash flow of $279M with about a 25% free-cash-flow margin. The company also reported roughly $5.0B in cash, cash equivalents and marketable securities as of June 30, 2026.

Customer Loyalty & Retention: Expansion within the installed base is a key driver, with about 75% of the 2025 revenue increase coming from existing customers and rising multi‑product adoption. Larger accounts are also expanding, as $100K+ ARR customers grew roughly 23% year over year to ~4,720 in Q2 2026.

Strong Revenue Growth: Net revenue rose at double‑digit rates in 2025 and continued to increase at a similar pace in early 2026, supported by higher gross dollar volume, cross‑border activity, and switched transactions. The multi‑quarter trend indicates consistent top‑line momentum rather than a one‑off spike.

Profitability: Operating income outpaced revenue growth in 2025, expanding margins, while net income and EPS also advanced strongly. This points to operating leverage as volumes and higher‑yield cross‑border flows scale.

Diversified Revenue Streams: Value‑added services and solutions grew markedly faster than the core network, with security, digital authentication, analytics, and consulting cited as key contributors. This mix shift broadens growth beyond card payment fees and supports resilience.

Investor Backing & Capital Strength: Recent financing includes a $50 million Series D anchored by Boehringer Ingelheim, following a Series C in 2025 and prior debt financing, indicating sustained access to strategic capital. The transfer of CT-155 commercialization responsibility alongside dedicated commercial funding further underscores capital support aligned with near-term growth plans.

Strategic Partnerships: Collaborations with major pharmaceutical companies such as Otsuka and Boehringer Ingelheim, alongside agreements with Indivior and Ultrahuman, reflect deepening partner engagement in development and commercialization. These alliances have produced FDA-authorized products and structured milestone and royalty pathways that reinforce external validation.

Product Line Growth: Multiple FDA authorizations (Rejoyn for MDD and CT-132 for migraine), the acquisition of AspyreRx, and an expanded pipeline spanning psychiatry, neurology, and cardiometabolic disease point to a broader, more mature portfolio. Positive Phase 3 results and commercialization preparations for CT-155 add momentum to this expansion.

Customer Loyalty & Retention: Autoship accounts for the vast majority of sales (over four-fifths) and is growing faster than total revenue, indicating a sticky, recurring base and higher retention. Evidence includes Autoship representing ~83% of FY2025 net sales and ~84.6% in Q2 FY2026 with high single‑digit to double‑digit growth.

Profitability: Operating metrics show expanding earnings power, with adjusted EBITDA up materially and margins improving alongside strong free cash flow. Observations include FY2025 adjusted EBITDA growth of ~26% with margin expansion and additional year‑over‑year gains reported in 1H FY2026.

Strong Market Position & Advantage: Chewy is characterized as the largest U.S. pet e‑tailer and a leading online pet‑supplies platform by GMV and digital presence, underpinning durable scale advantages. Multiple summaries highlight leadership in online pet retail, substantial Autoship penetration, and strong digital search share versus specialty peers.

Strong Revenue Growth: UK company filings indicate revenue rose from about £169.4m in 2023 to £197.0m in 2024, evidencing clear double-digit growth. Parent-company reporting in 2025 also attributed an increase in its ‘Other revenues’ to growth in Simply Business.

Profitability: Operating profit reportedly increased from roughly £24.2m to £45.9m in 2024, rising far faster than revenue. This points to improving margins and efficiency alongside scale.

Market Expansion: The business surpassed one million customers globally in 2024 and later reached one million in the UK, with continued activity in the U.S. and new partnerships and office investments. These milestones suggest ongoing expansion of reach and channels.

Profitability: Adjusted EBITDA and margins expanded, with Q2 2026 EBITDA up 30% year over year and margin improving to 37%, alongside higher net income. This pattern indicates operating leverage as earnings outpace the top line.

Strong Revenue Growth: Revenue rose 7% in 2025 and accelerated to 11% year over year in Q2 2026, with multiple sequential quarters showing improving trends. The recent trajectory points to faster growth rather than a flat profile.

Healthy Cash Flow: Free cash flow is guided to grow at more than 30% for 2026 and was later raised to the high-40% range, while Q2 2026 generated $57.4M in operating cash. Debt reduction in 1H 2026, including repayment of $205M in convertibles, further supports balance-sheet strength.

Market Expansion: Platform scale has expanded materially from roughly $500B and 1.5M accounts in 2016 to $2T+ and 5M+ accounts, alongside wins with large institutions such as Vanguard, Corient, and Elevation Point. Feedback suggests adoption is broadening across major managed‑account platforms and enterprise wealth firms.

Innovation-Driven Growth: Active investment in new capabilities—including AI initiatives (Vestmark Pulse, a Boston Center for AI Research and Development), direct indexing, and UMA integrations with alternatives—signals an innovation-led roadmap. These launches indicate ongoing product expansion that supports personalization and tax-aware implementation at scale.

Strategic Partnerships: Relationships with firms such as BlackRock, Vanguard, Capital Group, T. Rowe Price, iCapital, and Dynasty are extending distribution and solution breadth. Recent selections to power custom model portfolios and enterprise platforms reinforce integration into key industry ecosystems.

Investor Backing & Capital Strength: Capital resources include a $100M social bond, audited net asset growth in 2025, and $118M of impact investments deployed over four years. These signals indicate ample capacity to fund programs and expansion.

Market Expansion: Activities include the 2026 acquisition of Lab4U, scaling of Education at Work, and reported reach of 15M+ young people annually. Continued initiatives and campaigns following the 2026 rebrand point to a widening footprint.

Strategic Partnerships: Collaborations span major field builders and funders, such as the Britebound Center for Career Navigation at JFF and a grantee community of 100+ organizations across 49 states and Puerto Rico. These ties support national presence and program scaling.

Strong Revenue Growth: Recent results indicate FY2026 revenue rose 19% year over year to roughly $2.02B, with Q1 FY2027 revenue up 16% and ARR up 17%. This points to steady double‑digit expansion across both total and recurring revenue.

Customer Loyalty & Retention: Dollar-based net retention is reported around 110–111%, and ARR growth has tracked slightly ahead of revenue growth. These signals suggest existing customers are expanding usage alongside new logo additions.

Healthy Cash Flow: Company materials highlight strong free cash flow alongside growth, including substantial FY2026 free cash flow and robust margins in recent quarters. The business has also returned capital via notable share repurchases.

Strong Revenue Growth: Revenue grew 26% year over year in FY2024. ARR increased 30% in 2023 after crossing the $100M threshold in 2022.

Profitability: Operations remained profitable and cash‑flow positive in FY2024 while the organization expanded to just under 600 employees.

Investor Backing & Capital Strength: A July 2024 majority investment led by Vista Equity Partners (with TCV and KKR) valued the company at about $1.2B. This reflects substantial external capital support for continued expansion.

Strong Revenue Growth: Recent results show revenue rising from $1.62B in FY2023 to $2.17B in FY2024, $2.67B in FY2025, and about $3.35B in FY2026, with Q4 FY2026 up 25% year over year. This trajectory, alongside mid‑20% ARR growth, indicates continued expansion rather than a stall.

Healthy Cash Flow: Cash generation is growing, with free cash flow rising to about $779M in FY2026 and a free‑cash‑flow margin near 23%. Non‑GAAP operating metrics, including an ~80% gross margin, underscore operating leverage.

Strong Market Position & Advantage: Industry evaluations list the company as a Leader in the 2026 Gartner Magic Quadrants for both SSE and SASE, with five consecutive years of SSE leadership. Expanding large‑enterprise adoption and thousands of customers support a durable position in its core zero trust/SSE markets.

Strong Revenue Growth: Reported results show revenue rising from $3.67B (2023) to $4.77B (2024) to $6.05B (2025), with early 2026 revenue and guidance pointing to further gains. Q1 2026 continued to grow year over year, alongside expanding sportsbook handle and average monthly payers.

Profitability: Reported results show Adjusted EBITDA improving from $181M (2024) to $620M (2025) and a shift to positive GAAP net income in 2025. Guidance indicates substantial Adjusted EBITDA for 2026.

Product Line Growth: Company disclosures describe rising iGaming revenue in 2025 and the launch of new offerings like Predictions and a consolidated “super app.” These additions broaden the business beyond traditional sportsbook and DFS.

Strong Revenue Growth: Revenue has scaled materially, with ARR approaching the $400M mark and leadership targeting expansion toward $1B, alongside earlier signals such as 42% YoY ARR growth and very high renewal/net expansion. Feedback suggests recent indications of ~$300–350M revenue and expanding customer/end‑user coverage reinforce continued momentum.

Investor Backing & Capital Strength: A majority investment by Vista Equity Partners at an approximately $3B valuation signals strong capital support and confidence in the company’s scaling prospects. Feedback suggests this backing, including associated financing, enables continued product and geographic expansion.

Strong Market Position & Advantage: Repeated recognition as a Leader in Gartner’s DEX Magic Quadrant (2024–2026) and Forrester’s EUEM Wave points to sustained category leadership. Large‑scale enterprise adoption (e.g., 1,500+ customers and 25M+ employees served) further entrenches competitive positioning.

Strong Revenue Growth: Available evidence indicates sustained top-line expansion, with company-reported growth corroborated by repeated placements on independent fast-growth lists such as the Inc. 5000 and the Financial Times’ Americas ranking. These signals collectively point to continuing revenue momentum rather than a one-off spike.

Strong Hiring & Retention: Headcount has increased substantially since 2021, with recent statements describing ongoing hiring and acceleration year over year. Active postings across Cloud Engineering, ServiceNow, and related roles further indicate expansion of the workforce.

Market Expansion: The company extended its footprint beyond North America into EMEA and later into APAC, including initial hires in Australia. Growth in delivery activity and practice presence across these regions suggests a broader market reach.

Investor Backing & Capital Strength: Multiple funding rounds, including $8.2M in 2020, a $20M Series A in 2021 at a reported $100M valuation, and a $17M investment in 2026 from Enlightened Hospitality Investments, indicate strong capital support. The 2026 round is tied to product/engineering investment and go-to-market expansion.

Market Expansion: Customer reach spans hospitality, retail, transportation, healthcare, manufacturing, and logistics, with deployments cited across 32 countries and large-scale rollouts at brands such as McDonald’s and Elara Caring. A 2026 global partnership with Shake Shack and the addition of 700,000+ hospitality users in 2025 underscore geographic and vertical growth.

Strong Revenue Growth: ARR reportedly increased from $200K (Apr 2019) to $5M (Feb 2023), and U.S. growth of 159% was reported for fiscal 2023. These signals point to substantial revenue momentum even though more recent ARR figures are not disclosed.

Product Line Growth: Active ETFs are expanding, with MFS entering the U.S. ETF market in late 2024 and generating about $1.2B of net inflows and over $1.4B in AUM by year‑end 2025. The lineup continued to scale in 2026 with additional active ETF launches.

Strong Market Position & Advantage: Scale remains substantial, with AUM around $651.4B at year‑end 2025 and generally in the $640–$660B range through mid‑2026. Company materials also cite a top‑10 standing among U.S. active long‑term mutual fund and ETF managers.

Profitability: Earnings resilience is evident as higher average net assets supported slightly higher earnings and an improved pre‑tax operating margin in Q2 2026. This points to operational strength even amid flow headwinds.

Strong Market Position & Advantage: Ekotrope is positioned as the most widely used HERS rating software in the U.S., supporting roughly 1 in 4 new homes and serving 7,000+ builders with 400,000+ homes per year. Penetration spans hundreds of HERS rating companies and more than 40 utility new‑construction programs.

Investor Backing & Capital Strength: An $11M financing in October 2025, bringing tracked cumulative funding to about $15.9M, underscores continued capital support for expansion. Multiple independent profiles indicate the company has raised additional capital over time rather than a single one‑off event.

Product Line Growth: The company has expanded beyond its core RATER tool into Market Intelligence data products and solutions for utilities, builders, manufacturers, and lenders. Release history shows major version updates (e.g., Version 5.0 in 2025 with additional releases in 2026), indicating an active roadmap.

Resilient & Sustainable Growth: Revenue and ARR continued to rise, with ARR surpassing $300M by 2025 and revenue increasing in 2024. Feedback suggests growth has moderated from earlier hypergrowth into a steadier, efficiency‑focused trajectory while the customer base expanded to 4,500+.

Product Line Growth: Snyk Code reached $100M in ARR and newer offerings such as DAST and AI‑focused products (e.g., Evo) showed strong momentum. These developments indicate the platform is extending beyond its original core into additional security categories.

Market Expansion: Enterprise adoption intensified, with that segment driving a large share of new additions and AI security opening fresh routes to demand. Customer counts grew materially from 2024 into 2025, signaling broader market reach.

Investor Backing & Capital Strength: Capital raising has accelerated, including a $372M Series D in 2024 with total funding reported in the hundreds of millions to expand the pipeline and AI platform. Valuation has stepped up from roughly $1.04B (2021) to about $1.48B post‑money (2024), signaling strengthened private‑market positioning.

Strategic Partnerships: Partnerships are expanding, highlighted by a collaboration with Sanofi and OpenAI to build AI software for drug development and increased business‑development capacity via Entrepreneurs in Residence. Engagements with large pharma partners, including Sanofi, underscore growing external validation and deal flow.

Product Line Growth: The pipeline is broadening through multiple in‑licenses—such as an anti‑CD226 program, a CNS‑penetrant TYK2 inhibitor, and a miR‑124 activator—and progression to first‑in‑human dosing of BLKR201 in 2026. Stated plans to reach 10–15 assets over 3–5 years align with recent portfolio expansion and clinical advancement.

Strong Revenue Growth: ARR increased from $177M in 2024 to $218M in 2025, with reported ARR roughly doubling since 2021. Platform activity also expanded as GMV rose from $11.2B to about $14.6–$15B over the same period.

Profitability: The group was profitable throughout 2025, following earlier profitability in the core Platform business. This progression indicates improving operating leverage alongside continued expansion.

Diversified Revenue Streams: Newer products are contributing incremental revenue, with Mirakl Connect generating about $11.7M ARR in under a year and Mirakl Ads seeing a sharp rise in ad spend in 2025. Customer additions (45 global enterprises in 2025) and launches across marketplace and dropship broaden the commercial base.